Ignite Creation Date:
2025-12-24 @ 7:23 PM
Ignite Modification Date:
2026-03-01 @ 9:58 AM
Study NCT ID:
NCT06902103
Status:
COMPLETED
Last Update Posted:
2025-03-30
First Post:
2025-03-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pharmacokinetic Study of Single and Multiple Intravenous Administration of Nalbuphine Hydrochloride Injection in Healthy Chinese Volunteers
Sponsor:
Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
YZJ-NBF-PK-2302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None